APAC IPOs & Placements, Aequitas Research

Hong Jie Seow

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

Aequitas: EpiWorld International IPO - Poor Earnings And Premium Val

Aequitas: EpiWorld Trading - Priced At Mid-Range, Weak Insti Demand

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Epiworld International / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/epiworld-international" target="_blank" data-smartkarma-citation="entities:47626:1" rel="noopener">EpiWorld International (2111675D CH)</a> is looking to raise US$250m in its upcoming Hong Kong IPO.</li>
<li>EpiWorld is a global leader in the silicon carbide (SiC) epitaxy industry, according to CIC, and it is primarily engaged in the R&amp;D, production, and sales of SiC epitaxial wafers.</li>
<li>In this note, we look at the firm's PHIP updates.</li>
</ul>



EpiWorld International (2111675D CH) is looking to raise US$250m in its upcoming Hong Kong IPO.
EpiWorld is a global leader in the silicon carbide (SiC) epitaxy industry, according to CIC, and it is primarily engaged in the R&amp;D, production, and sales of SiC epitaxial wafers.
In this note, we look at the firm's PHIP updates.


Aequitas: EpiWorld International PHIP Updates